The rationale for the use of measles post-exposure prophylaxis in pregnant women: A review

References

• Advisory Committee on Epidemiology. Guidelines for the control of measles outbreaks in Canada. Canada Communicable Disease Report 21–21. 1995, Available at: http://www.phacaspc.gc.ca/publicat/ccdrrmtc/95vol21/dr2121ea.html (Accessed 28 May 2008)
   Google Scholar
• Advisory Committee on Immunization Practices (ACIP). Measles, mumps and rubella – vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps. Morbidity and Mortality Weekly Report 1998; 47(RR-8)1–57
   PubMedGoogle Scholar
• Atmar R L, Englund J A, Hammill H. Complications of measles during pregnancy. Clinical Infectious Diseases 1992; 14: 217–226
   PubMed Web of Science ®Google Scholar
• Black F L, Yannet H. Inapparent measles after gamma globulin administration. Journal of American Medical Association 1960; 173: 1183–1188
   PubMedGoogle Scholar
• Campbell H, Andrews N, Brown K E, Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. International Journal of Epidemiology 2007; 36: 1334–1348
   PubMed Web of Science ®Google Scholar
• Chiba M E, Saito M, Suzuki N, Honda Y, Yaegashi N. Measles infection in pregnancy. Journal of Infection 2003; 47: 40–44
   PubMed Web of Science ®Google Scholar
• Cruzado D, Massery-Spicher, Roux L, Delavelle J, Picard F, Haenggeli C A. Early onset and rapidly progressive SSPE. European Journal of Paediatrics 2002; 161: 438–441
   PubMed Web of Science ®Google Scholar
• Dasopoulou M, Covanis A. Subacute sclerosing panencephalitis after intrauterine infection. Acta Paediatrica 2004; 93: 1251–1253
   PubMed Web of Science ®Google Scholar
• Eberhart-Phillips J E, Frederick P D, Baron R C, Mascola L. Measles in pregnancy: a descriptive study of 58 cases. Obstetrics and Gynecology 1993; 82: 797–801
   PubMed Web of Science ®Google Scholar
• Ali M E, Albar H M. Measles in pregnancy: maternal morbidity and perinatal outcome. International Journal of Gynaecology and Obstetrics 1997; 59: 109–113
   PubMed Web of Science ®Google Scholar
• Endo A, Izumi H, Miyashita M, Taniguchi K, Okubo O, Harada K. Current efficacy of post exposure prophylaxis against measles with immunoglobulin. Journal of Paediatrics 2001; 138: 926–928
   PubMed Web of Science ®Google Scholar
• Gazala E, Karplus M, Liberman J R, Sarov I. The effect of maternal measles on the foetus. Paediatric Infectious Disease Journal 1985; 4: 203–204
   Google Scholar
• Gershon A A. Chicken pox, measles and mumps. Infectious diseases of the fetus and newborn infant, J S Remington, J O Klein. WB Saunders, Philadelphia 1990; 395–445
   Google Scholar
• Jespersen C S, Lttauer J, Sagild U. Measles as a cause of foetal defects. A retrospective study of ten measles epidemics in Greenland. Acta Paediatrica Scandinavica 1977; 66: 367–372
   PubMed Web of Science ®Google Scholar
• Kobayashi K, Tajima M, Toishi S, Fujimori K, Suzuki Y, Udagawa H. Fetal growth restriction associated with measles virus infection during pregnancy. Journal of Perinatal Medicine 2005; 33: 67–68
   PubMed Web of Science ®Google Scholar
• Moroi K, Sito S, Kurata T, Sata T, Yanagida M. Fetal death associated with measles virus infection of the placenta. American Journal of Obstetrics and Gynecology 1991; 164: 1107–1108
   PubMed Web of Science ®Google Scholar
• National Disease Surveillance Centre. Guidelines for the control of measles in Ireland. Recommendations of Measles Sub-committee of Scientific Advisory Committee. 2002, Available at: http://www.ndsc.ie/hpsc/AZ/VaccinePreventable/Measles/Publications/File,938,en.pdf (Accessed 28 May 2008)
   Google Scholar
• NSW Department of Health. Measles response protocol for public health units. 2004, Available at: http://www.health.nsw.gov.au/factsheets/guideline/measles.html (Accessed 28 May 2008)
   Google Scholar
• Office of National Statistics. 2006, Available at: http://www.statistics.gov.uk/cci/nugget.asp?ID=951 (Accessed 28 May 2008)
   Google Scholar
• Ohyama M, Fukui T, Tanaka Y, Kato K, Hoshino R, Sugawara T, et al. Measles virus infection in the placenta of monozygotic twins. Modern Pathology 2001; 14: 1300–1303
   PubMed Web of Science ®Google Scholar
• Ordman C W, Jennings J R, Janeway C A. Chemical, clinical and immunological studies on the products of human plasma fractionation. XII. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prevention and attenuation of measles. Journal of Clinical Investigation 1945; 23: 541–549
   Google Scholar
• Ramsay M, Gay N, Miller E, Rush M, White J, Morgan-Capner P, et al. The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Communicable Disease Report 1994; 4: 141–145
   Google Scholar
• Salisbury D, Ramsay M, Noakes K. Immunisation against infectious disease. 4th ed, D Salisbury, M Ramsay, K Noakes. The Stationery Office, London 2006; 209–234
   Google Scholar
• Stein S J, Greenspoon J S. Rubeola during pregnancy. Obstetrics and Gynecology 1991; 78: 925–929
   PubMed Web of Science ®Google Scholar
• Sawaishi Y, Abe T, Yano T, Ishikawa K, Takada G. SSPE following neonatal measles infection. Paediatric Neurology 1999; 20: 63–65
   PubMed Web of Science ®Google Scholar
• Siegel M. Congenital malformations following chickenpox, measles, mumps and hepatitis. Results of a Cohort study. Journal of American Medical Association 1973; 226: 1521–1524
   PubMed Web of Science ®Google Scholar
• Stokes J, Maris E P, Gellis S S. Chemical, clinical, and immunological studies on the products of human fractionation. XI. The use of concentrated normal human serum gamma globulin (human immune serum globulin) in the prophylaxis and treatment of measles. Journal of Clinical Investigation 1944; 23: 531–540
   PubMedGoogle Scholar
• Strebel P M, Papania M J. Measles vaccine. Vaccines5th ed, S Plotkin, W Orenstein, P Offit. WB Saunders, Philadelphia 2008; 353–398
   Google Scholar
• Vyse A J, Gay N J, Hesketh L M, Pebody R, Morgan-Capner P, Miller E. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century. Epidemiology and Infection 2006; 134: 1303–1312
   PubMed Web of Science ®Google Scholar
• Zwiauer K, Forstenpontner E, Popow-Kraupp T, Hauser E, Jellinger K A. Rapid progressive subacute sclerosing panencephalitis after perinatally acquired measles infection. Lancet 1995; 345: 1124
   PubMed Web of Science ®Google Scholar